NDA1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aurubis AG

Watchlist Manager

Watchlist

Price: 85.5 EUR -3.93% Market Closed

Market Cap: €7.5B

A	Aurubis AG F:NDA1	DE
K	KeyMed Biosciences Inc HKEX:2162	CN
V	Visteon Corp F:VS51	US
	Nitori Holdings Co Ltd TSE:9843	JP
C	China Overseas Land & Investment Ltd OTC:CAOVY	HK
D	Danaher Corp F:DAP	US
L	Linde PLC XETRA:LIN	UK
B	Bank Mandiri (Persero) Tbk PT XMUN:PQ9	ID
	Ajinomoto Co Inc F:AJI	JP
W	Wabash National Corp SWB:WA9	US
P	Prysmian SpA SWB:AEU	IT
S	Snam SpA F:SNM	IT
	Marathon Petroleum Corp NYSE:MPC	US

Profitability Summary

Aurubis AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

11%

Low 3Y Average Gross Margin

Gross Margin is Increasing

4% > 11%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

2% > 6%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

2% > 4%

Negative Free Cash Flow Margin

-1%

Negative 3Y Average Free Cash Flow Margin

-1%

Declining Free Cash Flow Margin

-1% > -1%

Positive ROE

18%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.